Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram on Q2 2021 Results – Earnings Call Transcript

Sarepta Therapeutics, Inc. (SRPT) Q2 2018 Results Conference Call August 4, 2021 4:30 PM ET
Company Participants
Mary Jenkins – Senior Manager, IR
Doug Ingram – President and CEO
Ian Estepan – EVP and CFO
Dallan Murray – SVP and Chief Commercial Officer

Click here to view the original article.